cell activity in various disease states Human large granular lymphocytes and their relationship to natural killer

[1]  D. Huhn,et al.  Large granular lymphocytes: Morphological and functional properties I. Results in normals , 1983, Blut.

[2]  J. Phillips,et al.  NKP-15: a monoclonal antibody reactive against purified human natural killer cells and granulocytes. , 1983, Immunology letters.

[3]  O. Majdic,et al.  Phenotypes of human large granular lymphocytes as defined by monoclonal antibodies. , 1983, Immunobiology.

[4]  C. Balch,et al.  Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life , 1983, The Journal of experimental medicine.

[5]  C. Huber,et al.  Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML. , 1982, Clinical and experimental immunology.

[6]  B. Bonavida,et al.  Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay. , 1982, Journal of immunology.

[7]  J. Reed,et al.  Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. , 1982, Journal of immunology.

[8]  D. Kraft,et al.  A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes. , 1982, Journal of Immunology.

[9]  W. Biddison,et al.  Phenotypes of human natural killer cell populations detected with monoclonal antibodies. , 1981, Journal of immunology.

[10]  J. Ortaldo,et al.  Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. , 1981, Journal of immunology.

[11]  N. Ghossein,et al.  Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. , 1981, Journal of immunology.

[12]  J. Pincott,et al.  Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies. , 1981, Cancer research.

[13]  C. Balch,et al.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). , 1981, Journal of immunology.

[14]  J. Hansen,et al.  Evidence for T cell nature and heterogeneity within natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) effectors: a comparison with cytolytic T lymphocytes (CTL). , 1981, Journal of immunology.

[15]  J. Ortaldo,et al.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells , 1981, The Journal of experimental medicine.

[16]  S. Targan,et al.  A single cell marker of active NK cytotoxicity: only a fraction of target binding lymphocytes are killer cells. , 1980, Journal of clinical & laboratory immunology.

[17]  T. Timonen,et al.  Effect of Leucocyte Interferon on Natural Killer Cells in Healthy Volunteers , 1980, Scandinavian journal of immunology.

[18]  E. Saksela,et al.  Isolation of human NK cells by density gradient centrifugation. , 1980, Journal of immunological methods.

[19]  E. Saksela,et al.  MORPHOLOGY AND SURFACE PROPERTIES OF HUMAN NK CELLS , 1980 .

[20]  E. Saksela,et al.  Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. , 1979, Cellular immunology.

[21]  O. Haller,et al.  Generation of natural killer cells: an autonomous function of the bone marrow , 1977, The Journal of experimental medicine.

[22]  C. Huber,et al.  Surface receptors on human haematopoietic cell lines. , 1976, Clinical and experimental immunology.